Staley Capital Advisers Inc Vyne Therapeutics Inc. Transaction History
Staley Capital Advisers Inc
- $2.2 Billion
- Q3 2024
A detailed history of Staley Capital Advisers Inc transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Staley Capital Advisers Inc holds 36,472 shares of VYNE stock, worth $112,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,472
Previous 36,472
-0.0%
Holding current value
$112,333
Previous $71,000
4.23%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VYNE
# of Institutions
2Shares Held
36.5KCall Options Held
0Put Options Held
0About VYNE Therapeutics Inc.
- Ticker VYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,005,600
- Market Cap $179M
- Description
- VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...